J项目国家先天性免疫缺陷患者护理数据表(2004-2021)
包含2004-2021年间三十个J项目国家先天性免疫缺陷患者的诊断与治疗参数表格数据。

基本信息
资源简介
J项目国家先天性免疫缺陷患者护理数据表(2004-2021)
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 22.35 KB,主题涵盖 J Project、immunodeficiencies、Eastern and Central Europe, Asia、ESID、parameters,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Table_1_Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.docx》。配套论文《Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee》发表于 Journal of Clinical Immunology(2020),DOI:10.1007/s10875-019-00737-x。源站首次发布:2022-12-16。
【数据内容】
源站原始描述:IntroductionThe J Project (JP) physician education and clinical research collaboration program was started in 2004 and includes by now 32 countries mostly in Eastern and Central Europe (ECE). Until the end of 2021, 344 inborn errors of immunity (IEI)-focused meetings were organized by the JP to raise awareness and facilitate the diagnosis and treatment of patients with IEI. ResultsIn this study, meeting profiles and major diagnostic and treatment parameters were studied. JP center leaders report…
【数据结构与技术规格】
文件数 1 个,合计 22.35 KB。Table_1_Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,22.35 KB。数据集 DOI:10.3389/fimmu.2022.1032358.s005。
【主题与分类】
源站学科分类:Transplantation Immunology、Tumour Immunology、Immunology not elsewhere classified、Immunology、Veterinary Immunology、Animal Immunology。主题标签:J Project、immunodeficiencies、Eastern and Central Europe, Asia、ESID、parameters。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Table_1_Care_of_patients_with_inborn_errors_of_immunity_in_thirty_J_Project_countries_between_2004_and_2021_docx/21739064
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Abolhassani, Hassan; Avcin, Tadej; Bahceciler, Nerin; Balashov, Dmitry; Bata, Zsuzsanna; Bataneant, Mihaela; et al. (2022). Table_1_Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.docx. Frontiers. Dataset
【使用注意】
· 源站最后修改于 2023-06-05,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Table_1_Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.docx
- DOI:10.3389/fimmu.2022.1032358.s005
- 发布日期:2022-12-16
- 文件数:1 个
- 文件总体积:22.35 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Table_1_Care_of_patients_with_inborn_errors_of_immunity_in_thirty_J_Project_countries_between_2004_and_2021_docx/21739064
命令行下载
curl -L -o "Table_1_Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.docx" "https://ndownloader.figshare.com/files/38568803"
文件清单
Table_1_Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.docx(22.35 KB)
文件总体积 22.35 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
IntroductionThe J Project (JP) physician education and clinical research collaboration program was started in 2004 and includes by now 32 countries mostly in Eastern and Central Europe (ECE). Until the end of 2021, 344 inborn errors of immunity (IEI)-focused meetings were organized by the JP to raise awareness and facilitate the diagnosis and treatment of patients with IEI.
ResultsIn this study, meeting profiles and major diagnostic and treatment parameters were studied. JP center leaders reported patients’ data from 30 countries representing a total population of 506 567 565. Two countries reported patients from JP centers (Konya, Turkey and Cairo University, Egypt). Diagnostic criteria were based on the 2020 update of classification by the IUIS Expert Committee on IEI. The number of JP meetings increased from 6 per year in 2004 and 2005 to 44 and 63 in 2020 and 2021, respectively. The cumulative number of meetings per country varied from 1 to 59 in various countries reflecting partly but not entirely the population of the respective countries. Altogether, 24,879 patients were reported giving an average prevalence of 4.9. Most of the patients had predominantly antibody deficiency (46,32%) followed by patients with combined immunodeficiencies (14.3%). The percentages of patients with bone marrow failure and phenocopies of IEI were less than 1 each. The number of patients was remarkably higher that those reported to the ESID Registry in 13 countries. Immunoglobulin (IgG) substitution was provided to 7,572 patients (5,693 intravenously) and 1,480 patients received hematopoietic stem cell therapy (HSCT). Searching for basic diagnostic parameters revealed the availability of immunochemistry and flow cytometry in 27 and 28 countries, respectively, and targeted gene sequencing and new generation sequencing was available in 21 and 18 countries. The number of IEI centers and experts in the field were 260 and 690, respectively. We found high correlation between the number of IEI centers and patients treated with intravenous IgG (IVIG) (correlation coefficient, cc, 0,916) and with those who were treated with HSCT (cc, 0,905). Similar correlation was found when the number
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fimmu.2022.1032358.s005(source: https://frontiersin.figshare.com/articles/dataset/Table_1_Care_of_patients_with_inborn_errors_of_immunity_in_thirty_J_Project_countries_between_2004_and_2021_docx/21739064)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




